Marinomed Biotech AG

MARI.VI · VIE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents€2€3€8€6
Short-Term Investments€0€0€0€0
Receivables€1€2€3€5
Inventory€1€1€2€1
Other Curr. Assets-€0€0€0€0
Total Curr. Assets€3€7€14€13
Property Plant & Equip (Net)€5€6€6€6
Goodwill€0€0€0€0
Intangibles€0€2€2€2
Long-Term Investments€0€0€0€0
Tax Assets€0€0€0-€0
Other NC Assets€0-€0€0€0
Total NC Assets€5€7€8€8
Other Assets€0€0€0-€0
Total Assets€8€15€22€21
Liabilities
Payables€2€2€1€2
Short-Term Debt€30€7€2€1
Tax Payable€0€0€0€0
Deferred Revenue€0€0€2€2
Other Curr. Liab.€1€1€2€1
Total Curr. Liab.€33€10€6€6
LT Debt€0€15€20€15
Deferred Rev, NC€0€0€0€0
Deferred Tax Liab, NC€0€0€0€0
Other NC Liab.€1€0€0€0
Total NC Liab.€1€15€20€15
Other Liabilities€0€0€0€0
Cap. Leases€0€0€0€0
Total Liabilities€34€25€26€21
Equity
Pref Stock€0€0€0€0
Common Stock€2€2€2€1
Retained Earnings-€71-€57-€50-€43
AOCI€43€45€44€42
Other Equity€0€0€0€0
Total Equity-€26-€10-€4€0
Supplemental Information
Minority Interest€0€0€0€0
Total Liab. & Tot. Equity€8€15€22€21
Net Debt€28€19€14€10
Marinomed Biotech AG (MARI.VI) Financial Statements & Key Stats | AlphaPilot